Discontinuous drug combination therapy in autoimmune ocular disorders

Purpose:  This study aimed to assess the effectiveness of a steroid‐sparing immunosuppressive treatment (IST) protocol in the control of severe or steroid‐resistant autoimmune ocular inflammatory diseases.

[1]  Douglas A Jabs,et al.  Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. , 2005, American journal of ophthalmology.

[2]  A. Okada Noninfectious uveitis: a scarcity of randomized clinical trials. , 2005, Archives of ophthalmology.

[3]  J. Forrester,et al.  Cyclosporine vs tacrolimus therapy for posterior and intermediate uveitis. , 2005, Archives of ophthalmology.

[4]  S. Lightman,et al.  Clinical outcome of chronic immunosuppression in patients with non‐infectious uveitis , 2005, Clinical & experimental ophthalmology.

[5]  D. Jabs,et al.  IMMUNOSUPPRESSION FOR POSTERIOR UVEITIS , 2005, Retina.

[6]  Y. Shoenfeld,et al.  Intraocular inflammation in autoimmune diseases. , 2004, Seminars in arthritis and rheumatism.

[7]  J. Dunn Review of immunosuppressive drug therapy in uveitis , 2004, Current opinion in ophthalmology.

[8]  L. Rostaing,et al.  COMPARISON OF INDUCTION THERAPY BASED ON CONTINUOUS VS. DISCONTINUOUS ADMINISTRATION OF ANTI-THYMOCYTE GLOBULINS IN RENAL-TRANSPLANT PATIENTS: EFFICACY AND LONG-TERM SAFETY , 2004 .

[9]  L. Rostaing,et al.  Comparison of induction based on continuous vs discontinuous administration of antithymocyte globulins in renal transplant patients: efficacy and long-term safety. , 2004, Transplantation Proceedings.

[10]  C. Foster,et al.  Pulse IV cyclophosphamide in ocular inflammatory disease: efficacy and short-term safety. , 2004, Ophthalmology.

[11]  B. Laganà,et al.  Autoimmune disorders: a concept of treatment based on mechanisms of disease , 2003, Springer Seminars in Immunopathology.

[12]  E. Woodle,et al.  Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on cd3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients , 2002, Transplantation.

[13]  Justine R. Smith,et al.  Management of uveitis: a rheumatologic perspective. , 2002, Arthritis and rheumatism.

[14]  N. Waheed,et al.  Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients. , 2001, Ophthalmology.

[15]  R. V. Van Gelder,et al.  Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. , 2000, American journal of ophthalmology.

[16]  J. Forrester,et al.  Cyclosporin A therapy in refractory non-infectious childhood uveitis , 1998, The British journal of ophthalmology.

[17]  C. Chan,et al.  Immunopathology of uveitis , 1985, The British journal of ophthalmology.

[18]  Q. Nguyen,et al.  Cicatricial Pemphigoid: Diagnosis and Treatment , 1996, International ophthalmology clinics.

[19]  C. Foster,et al.  Systemic immunosuppressive therapy and the occurrence of malignancy in patients with ocular inflammatory disease. , 1995, Ophthalmology.

[20]  O. Førre Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporine. Results of a 48-week multicenter study comparing low-dose cyclosporine with placebo. Norwegian Arthritis Study Group. , 1994, Arthritis and rheumatism.

[21]  H. Thiel,et al.  Zur Bedeutung der Autoimmunität bei verschiedenen Uveitisformen , 1991 .

[22]  M. Zierhut,et al.  [Significance of autoimmunity in various forms of uveitis]. , 1991, Klinische Monatsblätter für Augenheilkunde.

[23]  P. Tugwell,et al.  Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis , 1990, The Lancet.

[24]  L T Chylack,et al.  Lens opacities classification system II (LOCS II) , 1989, Archives of ophthalmology.

[25]  R. Nussenblatt,et al.  International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. , 1987, American journal of ophthalmology.

[26]  R. Nussenblatt,et al.  Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. , 1985, Ophthalmology.

[27]  A. Ahmed,et al.  Cyclophosphamide (Cytoxan). A review on relevant pharmacology and clinical uses. , 1984, Journal of the American Academy of Dermatology.